The therapeutic potential of thyrotropin releasing hormone (TRH) in Alzheimer's disease (AD)

Progress in Neuropsychopharmacology and Biological Psychiatry

Volumn 9, Issue 3, 1985, Pages 285-289

  Yarbrough, George G ^a,b   Pomara, Nuhzio ^b  

^a Paniabs Inc ^*  (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; amyotrophic lateral sclerosis; chollnergic neurons; thyrotropin releasing hormone

Indexed keywords

LEVODOPA; PROTIRELIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CENTRAL NERVOUS SYSTEM; CHOLINERGIC SYSTEM; DRUG INDICATION; DRUG THERAPY; HUMAN; MENTAL DISEASE; NERVOUS SYSTEM; PRIORITY JOURNAL; REVIEW; THERAPY;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; AUTONOMIC NERVOUS SYSTEM DISEASES; HUMAN; MENTAL DISORDERS; PARASYMPATHOMIMETICS; PROTIRELIN;

EID: 0021824945     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/0278-5846(85)90092-2     Document Type: Article

References (31)

1. Post-mortem levels of thyrotropln-releasing hormone and neurotensin in the amygdala in Alzheimer's disease, schizophrenia and depression
2. Treatment of Alzheimer's disease: a cautionary note
3. TRH has multiple actions in cortex
4. Aging and brain neurotransmitters
5. Physostigmine and arecoline: effects of intravenous infusions in Alzheimer presentie dementia
6. Neurotransmitter-related enzymes in senile dementia of the Alzheimer's type: the cholinergic hypothesis
7. Selective loss of central cholinergic neurons in Alzheimer's disease
8. Letter to the editor
9. Enhancement of memory processes in Alzheimer's disease with multiple dose intravenous physostigmine
10. Effect on weakness and spasticity in amyotrophic lateral sclerosis of thyrotropin-releasing hormone
11. Clinical nosology of the dementing illnesses
12. Alzheimer's disease
13. The cholinergic treatment strategy in aging and senile dementia
14. Evidence for a cholinergic projection to neocortex from neurons in basal forebrain
15. Regulatory peptides as a source of new drugs the clinical prospects for analogues of TRH which are resistant to metabolic degradation
16. Necropsy evidence of central cholinergic deficits in senile dementia
17. Effects of physostigmine and lecithin on memory in Alzheimer's disease
18. Failure of single-dose lecithin to alter aspects of central cholinergic activity in Alzheimer's disease
19. Pre- and postsynaptic neurochemical alterations in Alzheimer's disease
20. A post-mortem study of the cholinergic and GABA systems in senile dementia
21. Reduced amounts of immunoreactive somatostatin in the temporal cortex of senile dementia of Alzheimer type
22. Aging of the brain and dementia: an overview
23. 14C) glucose by tissue prisms from human neocortex
24. Cholinergic deficiency and Alzheimer's disease
25. Actions of TRH and cyclo (HIS-PRO) on spontaneous and evoked activity of cortical neurons
26. Oral physostigmine and lecithin improve memory in Alzheimer's disease
27. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain
28. TRH potentiates excitatory actions of acetylcholine on cerebral cortical neurons
29. On the neuropharmacology of thyrotropin releasing hormone (TRH)
30. Thyrotropin releasing hormone and CMS cholinergic neurons
31. Thyrotropin-releasing hormone, luteinizing hormone-releasing and Substance-P immunoreactivifcy in post-mortem brain from cases of Alzheimer-type dementia and Down's syndrome